• Dow futures fell while oil prices rose due to escalating attacks in Iran.
• Three U.S. servicemembers were killed in the attacks. • Key earnings reports from Google, Tesla, Intel, and GE Vernova are upcoming. • Gilead faces challenges with HIV treatments as patent expirations approach. • Eli Lilly is highlighted for strong earnings performance and is in a buy zone. • Intel prepares for its Q2 earnings report amid a chip market sell-off. • Biotech stocks remain attractive to investors despite AI stock declines.















